ABOUT    |  NEWS  |  PRODUCTS  |  TECHNOLOGY  |  INVESTOR RELATIONS  |  CAREER

CONTACT

Investor & Public Relations

  Mr. Joerg Petrass

Research & Development

  Dr. Matthias Schroff

Business Development

  Ms. Arlett Killat

NEWS

March 05, 2010

MOLOGEN AG receives approval for clinical study with cancer drug MGN1703


  more

January 08, 2010

MOLOGEN: Successful capital increase completed as planned


  more

NEWSLETTER

To subscribe to our Newsletter please

 click here